Travoprost PH&T is the generic of TRAVATAN (Alcon).

Travoprost, a prostaglandin F_2α analogue, is a highly selective full agonist which has a high affinity for the prostaglandin FP receptor, and reduces the intraocular pressure by increasing the outflow of aqueous humour via trabecular meshwork and uveoscleral pathways. Reduction of the intraocular pressure in man starts about 2 hours after administration and maximum effect is reached after 12 hours. Significant lowering of intraocular pressure can be maintained for periods exceeding 24 hours with a single dose.

THERAPEUTIC AREA
Ophthalmology

PRESENTATION
0.004% (40mcg/ml) ophthalmic solution (eye drops) in a 2.5ml bottle

INDICATION
Decrease of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.